Aggregated China Business Blogs



Shengtai Pharmaceutical Attractive at Current Levels

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
December 4, 2007|

Shengtai Pharmaceutical (SGTI.OB) is the largest domestic producer of pharmaceutical grade glucose in China. In 2006 SGTI began the process of bringing production of their primary raw material, corn starch, 'in house' by building a cornstarch manufacturing facility. This serves to increase margins & provide a steady supply of quality raw material required to reliably expand glucose production.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • Shengtai Pharmaceutical: A Steal at Current Prices
  • Shengtai Pharma: Cornstarch Not Considered "Industrial Use" of Corn
  • 5 China Stocks on This Week's Watch List
  • Huifeng Bio-Pharmaceutical Contracts With Xi'an Qinba Xintong Medical
  • China Shenghuo Pharmaceutical Hit on Revenue Decline

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |